Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets

Abstract excerpt

The clinical phenotype of human dilated cardiomyopathy (DCM) encompasses a broad spectrum of etiologically distinct disorders. As targeting of etiology-related pathogenic pathways may be more efficient than current standard heart failure treatment, we obtained the genomic expression profile of a DCM subtype characterized by cardiac inflammation to identify possible new therapeutic targets in humans. In this...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac Fibrosis and Remodeling
• Share to Connective Tissue Growth Factor Research
• Share to Protease and Inhibitor Mechanisms